Cardiac peroxisome proliferator-activated receptor γ is essential in protecting cardiomyocytes from oxidative damage

Cardiovascular Research

Volumn 76, Issue 2, 2007, Pages 269-279

  Ding, Guoliang ^a   Fu, Mingui ^b   Qin, Qianhong ^a   Lewis, William ^c   Kim, Ha Won ^c   Fukai, Tohru ^c   Bacanamwo, Methode ^a   Chen, Yuqing Eugene ^d   Schneider, Michael D ^e   Mangelsdorf, David J ^b   Evans, Ronald M ^f   Yang, Qinglin ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cardiac hypertrophy; Heart failure; Oxidative stress; PPARgamma; Sod2

Indexed keywords

ANTIOXIDANT; MANGANESE SUPEROXIDE DISMUTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; EXON; HEART HEMODYNAMICS; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARDIOMEGALY; HEART FAILURE; METALLOPORPHYRINS; MICE; MYOCYTES, CARDIAC; NF-KAPPA B; OXIDATIVE STRESS; PPAR GAMMA; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 36649035297     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2007.06.027     Document Type: Article

References (34)

1. Xu Y., Lu L., Greyson C., Lee J., Gen M., Kinugawa K., et al. Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs. Diabetes 52 (2003) 1187-1194
2. Barak Y., Nelson M.C., Ong E.S., Jones Y.Z., Ruiz-Lozano P., Chien K.R., et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4 (1999) 585-595
3. Matsusue K., Haluzik M., Lambert G., Yim S.H., Gavrilova O., Ward J.M., et al. Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111 (2003) 737-747
4. He W., Barak Y., Hevener A., Olson P., Liao D., Le J., et al. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 100 (2003) 15712-15717
5. Jones J.R., Barrick C., Kim K.A., Lindner J., Blondeau B., Fujimoto Y., et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 102 (2005) 6207-6212
6. Norris A.W., Chen L., Fisher S.J., Szanto I., Ristow M., Jozsi A.C., et al. Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. J Clin Invest 112 (2003) 608-618
7. Hevener A.L., He W., Barak Y., Le J., Bandyopadhyay G., Olson P., et al. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9 (2003) 1491-1497
8. Duan S.Z., Ivashchenko C.Y., Russell M.W., Milstone D.S., and Mortensen R.M. Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice. Circ Res 97 (2005) 372-379
9. Agah R., Frenkel P.A., French B.A., Michael L.H., Overbeek P.A., and Schneider M.D. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100 (1997) 169-179
10. Cheng L., Ding G., Qin Q., Huang Y., Lewis W., He N., et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10 (2004) 1245-1250
11. Peng X., Kraus M.S., Wei H., Shen T.L., Pariaut R., Alcaraz A., et al. Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice. J Clin Invest 116 (2006) 217-227
12. Manning W.J., Wei J.Y., Katz S.E., Litwin S.E., and Douglas P.S. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol 266 (1994) H1672-H1675
13. Zhou Z., Sun X., and James Kang Y. Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress. Exp Biol Med (Maywood) 227 (2002) 214-222
14. Patel M., Day B.J., Crapo J.D., Fridovich I., and McNamara J.O. Requirement for superoxide in excitotoxic cell death. Neuron 16 (1996) 345-355
15. Im H., Grass J.A., Johnson K.D., Boyer M.E., Wu J., and Bresnick E.H. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol 284 (2004) 129-146
16. Martowicz M.L., Grass J.A., Boyer M.E., Guend H., and Bresnick E.H. Dynamic GATA factor interplay at a multicomponent regulatory region of the GATA-2 locus. J Biol Chem 280 (2005) 1724-1732
17. Sam F., Kerstetter D.L., Pimental D.R., Mulukutla S., Tabaee A., Bristow M.R., et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J Card Fail 11 (2005) 473-480
18. Wallace D.C. Animal models for mitochondrial disease. Methods Mol Biol 197 (2002) 3-54
19. Zeviani M., Gellera C., Antozzi C., Rimoldi M., Morandi L., Villani F., et al. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet 338 (1991) 143-147
20. Suomalainen A., Paetau A., Leinonen H., Majander A., Peltonen L., and Somer H. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340 (1992) 1319-1320
21. Hiroi S., Harada H., Nishi H., Satoh M., Nagai R., and Kimura A. Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun 261 (1999) 332-339
22. Ferrari R., and Hearse D.J. Reperfusion injury: does it exist and does it have clinical relevance?. J Thromb Thrombolysis 4 (1997) 25-34
23. Yen H.C., Oberley T.D., Gairola C.G., Szweda L.I., and St Clair D.K. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys 362 (1999) 59-66
24. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11 (1995) 376-381
25. Lebovitz R.M., Zhang H., Vogel H., Cartwright Jr. J., Dionne L., Lu N., et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93 (1996) 9782-9787
26. Van Remmen H., Williams M.D., Guo Z., Estlack L., Yang H., Carlson E.J., et al. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol 281 (2001) H1422-H1432
27. Strassburger M., Bloch W., Sulyok S., Schuller J., Keist A.F., Schmidt A., et al. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic Biol Med 38 (2005) 1458-1470
28. Triepels R.H., Van Den Heuvel L.P., Trijbels J.M., and Smeitink J.A. Respiratory chain complex I deficiency. Am J Med Genet 106 (2001) 37-45
29. Loeffen J., Elpeleg O., Smeitink J., Smeets R., Stockler-Ipsiroglu S., Mandel H., et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 49 (2001) 195-201
30. Xu Y., Kiningham K.K., Devalaraja M.N., Yeh C.C., Majima H., Kasarskis E.J., et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 18 (1999) 709-722
31. Kim H.T., Kim Y.H., Nam J.W., Lee H.J., Rho H.M., and Jung G. Study of 5′-flanking region of human Cu/Zn superoxide dismutase. Biochem Biophys Res Commun 201 (1994) 1526-1533
32. Yoo H.Y., Chang M.S., and Rho H.M. Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234 (1999) 87-91
33. Hwang J., Kleinhenz D.J., Lassegue B., Griendling K.K., Dikalov S., and Hart C.M. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288 (2005) C899-C905
34. Girnun G.D., Domann F.E., Moore S.A., and Robbins M.E. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16 (2002) 2793-2801